Collaborative Stage for TNM 7 - Revised 11/12/2010 [ Schema ]
CS Site-Specific Factor 23
Multigene Signature Results
- Note 1: The results for the Oncotype DX test are expressed as a percentage Recurrence Score ranging from 0 to 100, with risk assessment in the categories of low, intermediate, and high.
- Note 2: The results for the MammaPrint test are expressed as low risk for distant recurrence and high risk for distant recurrence.
- Note 3: Code the score or results of the multigene signature assay recorded in CS Site-Specific Factor 22. Code the percentage score for Oncotype DX if available in preference to the risk assessment. Code the risk assessment for MammaPrint.
- Note 4: This information may not be available at diagnosis and may require follow-up with the physician.
|001-100||Score of 000 - 100|
(Actual score with leading zeroes to nearest whole percentage)
|200||Low risk of recurrence (good prognosis)|
|205||OBSOLETE DATA CONVERTED V0203|
See code 400
High risk of recurrence (poor prognosis)
|300||Intermediate risk of recurrence|
|400||High risk of recurrence (poor prognosis)|
|988||Not applicable: Information not collected for this case|
(If this information is required by your standard setter, use of code 988 may result in an edit error.)
|997||Test ordered, results not in chart|
|998||Test not done (test not ordered and not performed)|
|999||Unknown or no information|
Not documented in patient record